Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

DLX

Deluxe Corp's 2024 Net Income Surges

Deluxe Corporation has reported its fourth quarter and full-year 2024 results, indicating various changes in key financial metrics compared to the previous year.

For the full year 2024: Reported revenue decreased by 3.2%, while comparable adjusted revenue decreased by 1.2%. Net income improved significantly to $52.9 million from $26.2 million in 2023. Comparable adjusted EBITDA increased by 3.9% to $406.5 million. GAAP diluted EPS was $1.18 versus $0.59 in 2023, and comparable adjusted diluted EPS improved by 7.9% to $3.26. Cash from operating activities was $194.3 million, and free cash flow increased by 2.4% to $100.0 million. Total debt reduced by $89.8 million, while net debt reduced by $52.2 million.

For the fourth quarter of 2024: Revenue decreased by 3.1% from the previous year, and comparable adjusted revenue decreased by 2.1%. Net income decreased to $12.6 million from $15.0 million in the fourth quarter of 2023. * Comparable adjusted EBITDA margin increased by 60 basis points to 19.9%, and comparable adjusted diluted EPS was up by 9.1% year over year to $0.84.

Looking ahead to full-year 2025, the company expects: Revenue in the range of $2.090 to $2.155 billion Adjusted EBITDA of $415 to $435 million Adjusted diluted EPS of $3.25 to $3.55 Free cash flow of $120 to $140 million

Additionally, the board of directors approved a regular quarterly dividend of $0.30 per share, payable on March 3, 2025.

Deluxe Corporation's management will host a conference call to review the financial results and provide further insights.

The market has reacted to these announcements by moving the company's shares -1.2% to a price of $22.58. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS